Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1977 February; 70(2): 86–89.
PMCID: PMC1542925

Nonscorbutic effects of vitamin C: biochemical aspects.


There is a certain presumptive evidence for believing than AA has functions other than the simple prevention of classical scurvy; whether these extra-antiscorbutic functions are attributable to AA itself, or to one or more of its metabolites, is not known. Tissue saturation with AA would appear to provide a good insurance against defects in these extra-antiscorbutic areas. ttissue saturation is attainable by a daily intake of 100-150 mg in man; there are no compelling reasons for using megadoses of AA and the emphasis should be on the avoidance of chronic hypovitaminosis C. There is suggestive evidence that megadoses of AA could be physiologically disadvantageous--particularly with regard to in-utero exposure and in persons exposed to high environmental levels of toxic metals.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (667K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Barnes MJ, Kodicek E. Biological hydroxylations and ascorbic acid with special regard to collagen metabolism. Vitam Horm. 1972;30:1–43. [PubMed]
  • Berry WT, Darke SJ. Vitamins in health and disease. Practitioner. 1968 Aug;201(202):305–313. [PubMed]
  • Blackstone S, Hurley RJ, Hughes RE. Some inter-relationships between vitamin C (L-ascorbic acid) and mercury in the guinea-pig. Food Cosmet Toxicol. 1974 Aug;12(4):511–516. [PubMed]
  • Briggs MH. Letter: More vitamin C. Med J Aust. 1974 May 4;1(18):722–723. [PubMed]
  • Cochrane WA. Overnutrition in prenatal and neonatal life: a problem? Can Med Assoc J. 1965 Oct 23;93(17):893–899. [PMC free article] [PubMed]
  • Dykes MH, Meier P. Ascorbic acid and the common cold. Evaluation of its efficacy and toxicity. JAMA. 1975 Mar 10;231(10):1073–1079. [PubMed]
  • Davies JE, Wilson HK, Hughes RE. Food intake, dietary supplements and survival time of scorbutic guinea pigs. Nutr Metab. 1976;20(1):62–66. [PubMed]
  • Edgar JA. Ascorbic acid and biological alkylating agents. Nature. 1974 Mar 8;248(5444):136–137. [PubMed]
  • Fielding AM, Hughes RE. The absence of an inhibitory effect of metyrapone (2-methyl-1,2-di (3-pyridyl) propan-1-one) on hepatic microsomal hydroxylation in scurvy. Experientia. 1975 Dec 15;31(12):1394–1395. [PubMed]
  • Grimble RF, Hughes RE. A 'dehydroascorbic acid reductase' factor in guinea pig tissues. Experientia. 1967 May 15;23(5):362–362. [PubMed]
  • Hodges RE, Hood J, Canham JE, Sauberlich HE, Baker EM. Clinical manifestations of ascorbic acid deficiency in man. Am J Clin Nutr. 1971 Apr;24(4):432–443. [PubMed]
  • Kefalides NA. Structure and biosynthesis of basement membranes. Int Rev Connect Tissue Res. 1973;6:63–104. [PubMed]
  • Reid KB. A collagen-like amino acid sequence in a polypeptide chain of human C1q (a subcomponent of the first component of complement). Biochem J. 1974 Jul;141(1):189–203. [PubMed]
  • Rhead WJ, Schrauzer GN. Risks of long-term ascorbic acid overdosage. Nutr Rev. 1971 Nov;29(11):262–263. [PubMed]
  • Schlegel JU, Pipkin GE, Nishimura R, Shultz GN. The role of ascorbic acid in the prevention of bladder tumor formation. J Urol. 1970 Feb;103(2):155–159. [PubMed]
  • Stich HF, Karim J, Koropatnick J, Lo L. Mutogenic action of ascorbic acid. Nature. 1976 Apr 22;260(5553):722–724. [PubMed]
  • Tappel A, Fletcher B, Deamer D. Effect of antioxidants and nutrients on lipid peroxidation fluorescent products and aging parameters in the mouse. J Gerontol. 1973 Oct;28(4):415–424. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press